Product Information

AZELASTINE 0.1% (137 MCG) SPRY is a generic product labeled by Ascend Laboratories, LLC, priced at $0.2662 per ML under NDC 67877047750. Its NADAC has been published 457 times since Feb 14, 2018.

FDA first approved this application on Aug 18, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AZELASTINE 0.1% (137 MCG) SPRY

Azelastine
$0.2662per ML

Strength

137 ug/1

NDC

67877047750

Classification

Generic

Dosage Form

SPRAY, METERED

Route

NASAL

Effective Date

10/21/2026

Active Ingredients

AZELASTINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA208156

FDA Approved

8/18/2017

TE Code

AB

On Market Since

8/18/2017

Pharmacological Classes

Histamine H1 Receptor Antagonists
Histamine-1 Receptor Antagonist

Price Statistics

The NADAC for AZELASTINE 0.1% (137 MCG) SPRY has been published 457 times since Feb 14, 2018, and over the history we have for it it has declined 46.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2662 per ML
All-time high$0.4928 (Feb 14, 2018)
All-time low$0.2304 (Nov 20, 2024)
52-week high$0.2900
52-week low$0.2662
Median price$0.3027
Average price$0.3188
Largest weekly change-18.8% (Nov 20, 2024)
Weeks tracked457
Tracking sinceFeb 14, 2018

Price History

1W

0.0%

1M

-2.4%

3M

-4.6%

6M

-6.3%

1Y

-6.7%

3Y

-9.2%

5Y

-9.7%

All

-46.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Azelastine market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AZELASTINE 0.1% (137 MCG) SPRY?

The current National Average Drug Acquisition Cost (NADAC) for AZELASTINE 0.1% (137 MCG) SPRY, manufactured by Ascend Laboratories, LLC, is $0.2662 per ML (NDC 67877047750), effective Nov 11, 2026.

How has the price of AZELASTINE 0.1% (137 MCG) SPRY changed over time?

Over the history we have for it, the NADAC for AZELASTINE 0.1% (137 MCG) SPRY has declined 46.0%. It has been tracked across 457 weekly CMS publications since Feb 14, 2018.

What are the highest and lowest recorded NADAC prices for AZELASTINE 0.1% (137 MCG) SPRY?

Since Feb 14, 2018, the NADAC for AZELASTINE 0.1% (137 MCG) SPRY has ranged from a low of $0.2304 (Nov 20, 2024) to a high of $0.4928 (Feb 14, 2018), with a median of $0.3027 per ML.

Are there cheaper alternatives to AZELASTINE 0.1% (137 MCG) SPRY?

No other NADAC-published product currently shares the active ingredient and strength of AZELASTINE 0.1% (137 MCG) SPRY in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures AZELASTINE 0.1% (137 MCG) SPRY?

AZELASTINE 0.1% (137 MCG) SPRY (NDC 67877047750) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.